ArticleCancer chemotherapy and pharmacology2022

Discovery and pharmacological characterization of cetrelimab (JNJ-63723283), an anti-programmed cell death protein-1 (PD-1) antibody, in human cancer models.

Nikki DeAngelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.